沪深市场个股详情
688117 圣诺生物
- 29.41
- -0.27-0.91%
已收盘 11/08 15:00 (北京)
32.94亿总市值35.61市盈率TTM
30.39最高价29.31最低价4.12万手成交量29.98今开29.68昨收1.23亿成交额3.68%换手率46.83市盈率(静)1.12亿总股本36.9852周最高3.59市净率32.94亿流通值16.2652周最低35.62涨停价1.12亿流通股57.26历史最高23.74跌停价3.64%振幅14.38历史最低0.20股息TTM29.77平均价2.33万手内盘0.68%股息率TTM100股每手1.69万手外盘
圣诺生物关键统计数据
全部
显示同比
| (Q9)2024/09/30 | (Q6)2024/06/30 | (Q3)2024/03/31 | (FY)2023/12/31 | (Q9)2023/09/30 | (Q6)2023/06/30 | (Q3)2023/03/31 | (FY)2022/12/31 | (Q9)2022/09/30 | (Q6)2022/06/30 | |
|---|---|---|---|---|---|---|---|---|---|---|
| 营业总收入 | 16.00%3.38亿 | 14.44%1.99亿 | 27.65%1.04亿 | 9.93%4.35亿 | 11.82%2.91亿 | 3.78%1.74亿 | 0.96%8,151.66万 | 2.38%3.96亿 | -6.70%2.6亿 | -13.49%1.68亿 |
| 营业收入 | 16.00%3.38亿 | 14.44%1.99亿 | 27.65%1.04亿 | 9.93%4.35亿 | 11.82%2.91亿 | 3.78%1.74亿 | 0.96%8,151.66万 | 2.38%3.96亿 | -6.70%2.6亿 | -13.49%1.68亿 |
| 营业总成本 | 6.79%2.72亿 | 11.99%1.76亿 | 19.14%8,693.26万 | 11.01%3.57亿 | 17.38%2.55亿 | 5.89%1.58亿 | 10.64%7,296.37万 | 1.61%3.22亿 | -5.88%2.17亿 | -10.23%1.49亿 |
| 营业成本 | 28.56%1.39亿 | 31.65%8,040.32万 | 32.20%3,837.34万 | 15.37%1.58亿 | 14.95%1.08亿 | 2.29%6,107.29万 | 10.01%2,902.69万 | 26.13%1.37亿 | 33.17%9,374.98万 | 26.27%5,970.75万 |
| 营业税金及附加 | 21.51%316.69万 | 41.14%257.89万 | 122.81%132.43万 | -14.54%403.41万 | -22.69%260.63万 | -26.67%182.71万 | -53.10%59.43万 | -1.71%472.06万 | 1.68%337.14万 | 7.56%249.16万 |
| 销售费用 | -38.05%4,935.4万 | -26.85%3,567.76万 | 19.93%2,317.65万 | -4.65%1.08亿 | 6.91%7,966.44万 | -4.27%4,877.2万 | -20.92%1,932.54万 | -25.37%1.13亿 | -39.40%7,451.69万 | -43.38%5,094.68万 |
| 管理费用 | 11.04%4,528.03万 | -0.75%3,048.12万 | -25.85%1,261.85万 | 17.92%5,386.3万 | 39.73%4,077.98万 | 45.14%3,071.24万 | 86.15%1,701.77万 | 13.75%4,567.6万 | 7.65%2,918.54万 | 10.10%2,116.1万 |
| 财务费用 | 101.61%709.41万 | 74.16%349.35万 | -5.30%202.32万 | 417.50%491.08万 | 232.06%351.87万 | 232.99%200.59万 | 639.17%213.65万 | 16.31%-154.67万 | -23.85%-266.45万 | -434.76%-150.83万 |
| -利息费用 | 31.10%895.59万 | 21.24%526.73万 | 47.75%293.64万 | 164.68%926.49万 | 199.24%683.16万 | 303.35%434.47万 | 339.82%198.74万 | 1,949.84%350.04万 | 8,811.52%228.3万 | --107.72万 |
| -利息收入 | 37.43%-170.8万 | 38.82%-123.19万 | -14.86%-83.85万 | -86.50%-391.99万 | -96.23%-272.97万 | -78.71%-201.36万 | -20.48%-73万 | 23.19%-210.18万 | 46.39%-139.1万 | -70.84%-112.67万 |
| 研发费用 | 40.22%2,857.83万 | 80.85%2,383.29万 | 93.65%941.68万 | 24.74%2,904.77万 | 8.23%2,038.1万 | -17.69%1,317.85万 | -4.87%486.29万 | 69.40%2,328.64万 | 111.11%1,883.18万 | 120.57%1,601.18万 |
| 信用减值损失 | -58.99%-94.3万 | 397.80%195.45万 | 408.03%143.14万 | 12.71%-304.72万 | -3.57%-59.31万 | -200.53%-65.63万 | -208.26%-46.47万 | -171.12%-349.09万 | -275.10%-57.27万 | 13.44%-21.84万 |
| 资产减值损失 | -10.70%-472.15万 | -88.99%-475.15万 | -289.31%-87.45万 | -2.68%-493.02万 | -361.49%-426.5万 | -4,699.08%-251.41万 | -3,393.77%-22.46万 | -280.75%-480.17万 | -221.60%-92.42万 | 90.59%-5.24万 |
| 非经营性净收益 | ||||||||||
| 投资净收益 | 169.31%62.41万 | 272.73%69.8万 | 153.81%29.89万 | -157.63%-142.1万 | -163.84%-90.05万 | -146.82%-40.41万 | -150.70%-55.55万 | 68.33%246.57万 | --141.05万 | --86.31万 |
| -其中:对联营合营企业的投资收益 | ---- | ---- | ---- | -66.18%-316.71万 | ---- | ---- | ---- | ---190.59万 | ---- | ---- |
| 资产处置收益 | -250.15%-3,717.56 | 103.30%35 | 103.30%35 | 98.66%-1,061.71 | 90.48%-1,061.71 | 90.48%-1,061.71 | 90.48%-1,061.71 | -487.73%-7.94万 | ---1.12万 | ---1.12万 |
| 其他收益 | -67.77%360.33万 | -68.01%343.58万 | -82.22%160.71万 | 156.62%1,295.62万 | 255.64%1,118.04万 | 334.04%1,074.03万 | 579.05%904.01万 | -30.84%504.89万 | -31.97%314.37万 | -32.59%247.45万 |
| 营业利润 | 53.53%6,438.22万 | 1.61%2,380.72万 | 19.82%1,958.76万 | 11.34%8,110.11万 | -9.79%4,193.54万 | 7.69%2,342.96万 | -7.31%1,634.71万 | -3.92%7,284.11万 | -12.68%4,648.72万 | -29.20%2,175.55万 |
| 加:营业外收入 | -34.82%20.76万 | -89.47%2.61万 | 265,909.48%2.13万 | 9,770.38%33.35万 | 3,473.84%31.85万 | 2,926.72%24.79万 | -99.90%8.02 | -83.59%3,378.58 | -92.56%8,911.62 | -93.14%8,190.15 |
| 减:营业外支出 | -43.79%66.88万 | -40.29%53.34万 | 1,780.04%30.76万 | 173.22%131.31万 | 207.97%118.98万 | 151.89%89.33万 | -80.75%1.64万 | -91.01%48.06万 | -86.35%38.63万 | -85.13%35.47万 |
| 利润总额 | 55.66%6,392.1万 | 2.26%2,329.99万 | 18.19%1,930.13万 | 10.72%8,012.15万 | -10.94%4,106.41万 | 6.42%2,278.41万 | -7.00%1,633.07万 | 2.66%7,236.39万 | -8.74%4,610.98万 | -24.78%2,140.91万 |
| 减:所得税费用 | 13.36%710.5万 | -40.00%158.16万 | 24.08%285.12万 | 24.34%979.71万 | -11.77%626.79万 | -4.79%263.6万 | -29.65%229.78万 | -14.68%787.95万 | -5.18%710.4万 | -37.84%276.85万 |
| 净利润 | 63.28%5,681.6万 | 7.79%2,171.83万 | 17.23%1,645.01万 | 9.06%7,032.44万 | -10.79%3,479.62万 | 8.09%2,014.81万 | -1.82%1,403.29万 | 5.28%6,448.44万 | -9.36%3,900.58万 | -22.36%1,864.05万 |
| 持续经营净利润 | 63.28%5,681.6万 | 7.79%2,171.83万 | 17.23%1,645.01万 | 9.06%7,032.44万 | -10.79%3,479.62万 | 8.09%2,014.81万 | -1.82%1,403.29万 | 5.28%6,448.44万 | -9.36%3,900.58万 | -22.36%1,864.05万 |
| 减：少数股东损益 | ---13.06万 | ---6.93万 | ---2.21万 | ---1.27万 | ---- | ---- | ---- | ---- | ---- | ---- |
| 归属于母公司所有者的净利润 | 63.66%5,694.66万 | 8.14%2,178.76万 | 17.38%1,647.22万 | 9.08%7,033.71万 | -10.79%3,479.62万 | 8.09%2,014.81万 | -1.82%1,403.29万 | 5.28%6,448.44万 | -9.36%3,900.58万 | -22.36%1,864.05万 |
| 每股收益 | ||||||||||
| 基本每股收益 | 64.52%0.51 | 5.56%0.19 | 15.38%0.15 | 8.62%0.63 | -11.43%0.31 | 5.88%0.18 | -27.78%0.13 | -31.76%0.58 | -43.55%0.35 | -55.26%0.17 |
| 稀释每股收益 | 64.52%0.51 | 5.56%0.19 | 15.38%0.15 | 6.90%0.62 | -11.43%0.31 | 5.88%0.18 | -27.78%0.13 | -31.76%0.58 | -43.55%0.35 | -55.26%0.17 |
| 其他综合收益 | ||||||||||
| 综合收益总额 | 63.28%5,681.6万 | 7.79%2,171.83万 | 17.23%1,645.01万 | 9.06%7,032.44万 | -10.79%3,479.62万 | 8.09%2,014.81万 | -1.82%1,403.29万 | 5.28%6,448.44万 | -9.36%3,900.58万 | -22.36%1,864.05万 |
| 归属于母公司所有者的综合收益总额 | 63.66%5,694.66万 | 8.14%2,178.76万 | 17.38%1,647.22万 | 9.08%7,033.71万 | -10.79%3,479.62万 | 8.09%2,014.81万 | -1.82%1,403.29万 | 5.28%6,448.44万 | -9.36%3,900.58万 | -22.36%1,864.05万 |
| 归属于少数股东的综合收益总额 | ---13.06万 | ---6.93万 | ---2.21万 | ---1.27万 | ---- | ---- | ---- | ---- | ---- | ---- |
| 货币单位 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 | 人民币 |
| 会计准则 | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) | 中国会计准则(2007) |
| 审计意见 | -- | -- | -- | 无保留意见 | -- | -- | -- | 无保留意见 | -- | -- |
| 会计师事务所 | -- | -- | -- | 天健会计师事务所(特殊普通合伙) | -- | -- | -- | 天健会计师事务所(特殊普通合伙) | -- | -- |
FY：Financial Year 年度报告，相当于上市公司向SEC披露的10-K文件。
Q：Quarter 季度报告，相当于上市公司向SEC披露的10-Q文件，其中Q1、Q2、Q3、Q4为单季报，跨度为3个月；Q6、Q9为累计季报，Q6为6个月，Q9为9个月。
分析
目标价预测
暂无数据
热议
沪深
综合热度
股票代码
最新价
涨跌幅
暂无数据